tirofiban has been researched along with Complication, Postoperative in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 14 (51.85) | 29.6817 |
| 2010's | 9 (33.33) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, M; Liu, R; Luo, Y; Yan, F | 1 |
| Li, H; Liu, C; Wang, J; Wang, S; Xue, Y | 1 |
| Çavuşoğlu, Y; Iskenderov, K; Mutlu, F; Şenol, U; Tahmazov, S; Ulus, T | 1 |
| Hohmann, C; Michels, G; Nettersheim, FS; Pfister, R | 1 |
| Gao, C; Hu, D; Li, M; Liu, H; Wang, X; Yang, H; Zhang, Y; Zhu, Z | 1 |
| Changjiang, H; Jian, Q; Liang, Y; Puqing, L; Xiaolong, G; Yuan, Z | 1 |
| Badran, AV; Barbosa, R; Figueiredo, GL; Haddad, JL; Lago, IM; Lima, MO; Marin, JA; Novaes, GC; Pavão, RB; Schmidt, A | 1 |
| Carteaux, JP; Durand, M; Hacquard, M; Lecompte, T | 1 |
| Beiras-Fernandez, A; Jiru, P; Kowert, A; Reichart, B; Schmoeckel, M; Spannagl, M; Weis, M | 1 |
| Doraiswamy, VA | 1 |
| Armstrong, PW; Bolognese, L; Braunwald, E; Califf, RM; Durand, E; Giugliano, RP; Harrington, RA; Hasselblad, V; Kong, DF; Moliterno, DJ; Newby, LK; Prabhakaran, D; Rasoul, S; Stone, GW; Théroux, P; Tricoci, P; Van de Werf, F; White, HD | 1 |
| De Caterina, R; Grove, EL; Huber, K; Kristensen, SD; Moliterno, DJ; Neumann, FJ; Würtz, M | 1 |
| Cho, YD; Han, MH; Jung, KH; Kang, HS; Kim, JE; Lee, JY; Seo, JH | 1 |
| Anderson, HV; Assali, AR; Fujise, K; Ghani, M; Moustapha, A; Rosales, OR; Salloum, J; Schroth, G; Sdringola, S; Smalling, RW | 1 |
| Bailey, S; Eles, G; Jarmolowski, C; Tan, WA; Toursakissian, B; Wholey, MH | 1 |
| Qureshi, AI | 1 |
| Baglini, R; Capuano, C; Danzi, GB; Sesana, M | 1 |
| Chang, HW; Chen, CJ; Chen, MC; Chen, SM; Cheng, CI; Hung, WC; Kuo, FY; Wu, CJ; Yang, CH; Yip, HK | 1 |
| Dambrink, JH; de Boer, MJ; Ernst, NM; Gosselink, AT; Hoorntje, JC; Miedema, K; Ottervanger, JP; Slingerland, RJ; Suryapranata, H; van 't Hof, AW; Zijlstra, F | 1 |
| Augoustides, JG | 1 |
| di Spilimbergo, SS; Padula, E; Penzo, M; Rampazzo, A; Squaquara, R | 1 |
| Higman, DJ; Imray, CH; Jarvi, K; Marshall, C; Tiivas, CA; van Dellen, D | 1 |
| Anderson, HL; Edmunds, LH; Gikakis, N; Gorman, JH; Gould, RJ; Hiramatsu, Y; Marcinkiewicz, C; Niewiarowski, S | 1 |
| Bassand, JP | 1 |
| Bizzarri, F; Davoli, G; Frati, G; Lucidi, M; Muzzi, L; Neri, E; Scolletta, S; Toscano, T; Tucci, E | 1 |
| Bertrand, M; Cohen, DJ; Cohen, EA; Cohen, M; DiBattiste, PM; Grines, CL; Herrmann, HC; Moliterno, DJ; Moses, JW; Neumann, FJ; Powers, ER; Stone, GW; Topol, EJ; Wolski, K | 1 |
4 review(s) available for tirofiban and Complication, Postoperative
| Article | Year |
|---|---|
Safety and Efficacy of Tirofiban Combined with Statins in the Perioperative Period of Intracranial Aneurysms: Systematic Review and Meta-Analysis.
Topics: Aneurysm, Ruptured; Embolization, Therapeutic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Aneurysm; Perioperative Period; Postoperative Complications; Retrospective Studies; Tirofiban; Treatment Outcome; Tyrosine | 2022 |
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.
Topics: Acetates; Acute Coronary Syndrome; Administration, Cutaneous; Angioplasty; Electrocardiography; Eptifibatide; Hemorrhage; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Risk; Survival Analysis; Tirofiban; Tyrosine | 2011 |
Contemporary use of glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Acute Coronary Syndrome; Angioplasty; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Thrombosis; Tirofiban; Tyrosine | 2012 |
Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease.
Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Complications; Drug Therapy, Combination; Eptifibatide; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Oligosaccharides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
7 trial(s) available for tirofiban and Complication, Postoperative
| Article | Year |
|---|---|
Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Drug Administration Schedule; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Complications; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2013 |
Tirofiban Combined with Fondaparinux for Post-PCI Treatment of Patients with Acute Coronary Syndrome and Mild Renal Insufficiency.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Drug Combinations; Female; Fondaparinux; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Polysaccharides; Postoperative Complications; Renal Insufficiency; Tirofiban; Tyrosine | 2015 |
In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study.
Topics: Aged; Brazil; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Pilot Projects; Placebos; Platelet Aggregation Inhibitors; Postoperative Complications; Predictive Value of Tests; Stents; Time Factors; Tirofiban; Tyrosine | 2016 |
Intra-arterial tirofiban infusion for thromboembolic complication during coil embolization of ruptured intracranial aneurysms.
Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Comorbidity; Embolization, Therapeutic; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Intracranial Aneurysm; Intracranial Embolism; Male; Middle Aged; Postoperative Complications; Prevalence; Radiography; Republic of Korea; Tirofiban; Treatment Outcome; Tyrosine | 2012 |
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Survival Analysis; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Artery Bypass; Coronary Thrombosis; Double-Blind Method; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIb-IX Complex; Postoperative Complications; Retreatment; Time Factors; Tirofiban; Tyrosine | 1997 |
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial.
Topics: Abciximab; Acute Disease; Aged; Antibodies, Monoclonal; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Disease-Free Survival; Double-Blind Method; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Severity of Illness Index; Stents; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
16 other study(ies) available for tirofiban and Complication, Postoperative
| Article | Year |
|---|---|
Safety and Efficacy of Tirofiban Bridging Therapy During a Hybrid Carotid Artery Stenting and Off-pump Coronary Artery Bypass Grafting Surgery: A Single-center Study.
Topics: Carotid Arteries; Carotid Stenosis; Coronary Artery Bypass; Coronary Artery Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Stroke; Tirofiban; Treatment Outcome | 2023 |
High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Thrombosis; Tirofiban; Tyrosine | 2017 |
[Severe tirofiban-induced thrombocytopenia and thrombotic microangiopathy after percutaneous coronary intervention].
Topics: Aged; Fatal Outcome; Humans; Male; Percutaneous Coronary Intervention; Postoperative Complications; Thrombocytopenia; Thrombotic Microangiopathies; Tirofiban | 2019 |
Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
Topics: Anticoagulants; Cardiopulmonary Bypass; Drug Therapy, Combination; Factor VIIa; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Postoperative Hemorrhage; Reoperation; Thrombocytopenia; Tirofiban; Tyrosine | 2008 |
Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting.
Topics: Acute Coronary Syndrome; Acute Disease; Angina, Unstable; Coronary Angiography; Coronary Artery Bypass, Off-Pump; Follow-Up Studies; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Postoperative Complications; Preoperative Care; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
Letter by Doraiswamy regarding article, "Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring
Topics: Anticoagulants; Aspirin; Clopidogrel; Confounding Factors, Epidemiologic; Double-Blind Method; Drug Resistance; Elective Surgical Procedures; Hemorrhage; Heparin; Humans; Myocardial Revascularization; Patient Selection; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Research Design; Thromboembolism; Ticlopidine; Tirofiban; Tyrosine | 2010 |
Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Catheters, Indwelling; Cohort Studies; Dose-Response Relationship, Drug; Equipment Failure; Female; Femoral Artery; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Ischemia; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Retrospective Studies; Time Factors; Tirofiban; Tyrosine; Vascular Diseases | 2003 |
Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angioplasty; Antibodies, Monoclonal; Carotid Stenosis; Case-Control Studies; Eptifibatide; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Retrospective Studies; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Adjunctive use of platelet glycoprotein IIb/IIIa inhibitors for carotid angioplasty and stent placement: time to say good bye?
Topics: Abciximab; Angioplasty; Antibodies, Monoclonal; Carotid Stenosis; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Safety of a high bolus dose of tirofiban in patients undergoing coronary stent placement.
Topics: Aged; Cardiac Catheterization; Chi-Square Distribution; Coronary Angiography; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Transradial application of PercuSurge GuardWire device during primary percutaneous intervention of infarct-related artery with high-burden thrombus formation.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Equipment Design; Female; Fibrinolytic Agents; Humans; Incidence; Intraoperative Care; Male; Middle Aged; Myocardium; Postoperative Complications; Taiwan; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Injections, Intravenous; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Tirofiban; Tyrosine | 2007 |
Hypercoagulability due to homocystinuria in a case of head and neck reconstruction resolved with combined systemic therapy.
Topics: Carcinoma, Squamous Cell; Fibrinolytic Agents; Head and Neck Neoplasms; Homocystinuria; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Surgical Flaps; Thrombophilia; Tirofiban; Tissue Plasminogen Activator; Tyrosine | 2008 |
Transcranial Doppler ultrasonography-directed intravenous glycoprotein IIb/IIIa receptor antagonist therapy to control transient cerebral microemboli before and after carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Combined Modality Therapy; Endarterectomy, Carotid; Female; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Postoperative Complications; Preoperative Care; Tirofiban; Tyrosine; Ultrasonography, Doppler, Transcranial; Ultrasonography, Interventional | 2008 |
Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons.
Topics: Animals; Bleeding Time; Cardiopulmonary Bypass; Hemodynamics; Hemorrhage; Heparin; Papio; Platelet Aggregation Inhibitors; Platelet Count; Postoperative Complications; Tirofiban; Tyrosine | 1997 |
Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
Topics: Blood Transfusion; Case-Control Studies; Coronary Artery Bypass; Emergencies; Female; Heparin; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Postoperative Hemorrhage; Time Factors; Tirofiban; Tyrosine | 2001 |